Columbia Asset Management Merck & Co., Inc. Transaction History

Columbia Asset Management

$504 Million
Q2 2025

A detailed history of Columbia Asset Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Columbia Asset Management holds 115,552 shares of MRK stock, worth $9.79 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

115,552

Previous 122,648 5.79%

Holding current value

$9.79 Million

Previous $11 Million 16.91%

% of portfolio

1.81%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	SELL	$73.47 - $87.12 $521,343 - $618,203	-7,096 Reduced 5.79%	115,552 $9.15 Million
Q1 2025 Apr 10, 2025	SELL	$83.01 - $101.02 $641,750 - $780,985	-7,731 Reduced 5.93%	122,648 $11 Million
Q4 2024 Feb 12, 2025	SELL	$96.31 - $114.76 $407,487 - $485,549	-4,231 Reduced 3.14%	130,379 $13 Million
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $531,519 - $616,734	-4,782 Reduced 3.43%	134,610 $15.3 Million
Q2 2024 Aug 05, 2024	SELL	$123.8 - $132.96 $77,746 - $83,498	-628 Reduced 0.45%	139,392 $17.3 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $128,330 - $139,654	-1,281 Reduced 0.91%	140,020 $15.3 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $163,381 - $181,441	-1,587 Reduced 1.11%	141,301 $14.5 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $579,434 - $631,557	-5,335 Reduced 3.6%	142,888 $16.5 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $112,410 - $125,427	-1,092 Reduced 0.73%	148,223 $15.8 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $7,607 - $9,753	87 Added 0.06%	149,315 $16.6 Million
Q3 2022 Nov 03, 2022	BUY	$84.53 - $94.96 $251,392 - $282,411	2,974 Added 2.03%	149,228 $12.9 Million
Q2 2022 Aug 26, 2022	SELL	$83.49 - $94.64 $101,189 - $114,703	-1,212 Reduced 0.82%	146,254 $13.3 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $62,016 - $77,683	858 Added 0.59%	147,466 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $134,830 - $148,279	1,881 Added 1.3%	146,608 $11 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $953,614 - $1.05 Million	-13,563 Reduced 8.57%	144,727 $11.3 Million
Q1 2021 May 28, 2021	BUY	$68.86 - $81.11 $98,607 - $116,149	1,432 Added 0.91%	158,290 $12.2 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $56,267 - $62,445	784 Added 0.5%	156,858 $12.8 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $143,505 - $162,664	1,961 Added 1.27%	156,074 $12.9 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $47,533 - $54,087	-675 Reduced 0.44%	154,113 $11.9 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $106,698 - $147,888	1,684 Added 1.1%	154,788 $11.9 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $7,990 - $9,016	-103 Reduced 0.07%	153,104 $139 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $74,558 - $81,271	980 Added 0.64%	153,207 $12.9 Million
Q2 2019 Aug 15, 2019	SELL	$69.84 - $81.59 $64,951 - $75,878	-930 Reduced 0.61%	152,227 $12.8 Million
Q1 2019 May 20, 2019	SELL	$69.58 - $79.36 $2,852 - $3,253	-41 Reduced 0.03%	153,157 $12.7 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $199,960 - $232,051	-3,065 Reduced 1.96%	153,198 $11.7 Million
Q3 2018 Nov 06, 2018	BUY	$57.69 - $67.84 $37,902 - $44,570	657 Added 0.42%	156,263 $11.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $31,107 - $36,548	-612 Reduced 0.39%	155,606 $9.45 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $78,376 - $91,095	1,538 Added 0.99%	156,218 $8.51 Million
Q4 2017 Feb 05, 2018	SELL	$51.62 - $61.64 $15,950 - $19,046	-309 Reduced 0.2%	154,680 $8.7 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $9.09 Million - $9.78 Million	154,989	154,989 $9.92 Million

Others Institutions Holding MRK

# of Institutions

3,888

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $215B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Merck & Co., Inc. Transaction History